Global Diabetic Macular Edema Market Size By Product (Intravitreal Injections, Intravitreal Implants), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Geographic Scope And Forecast

Diabetic Macular Edema Market Size And Forecast

Diabetic Macular Edema Market size was valued at USD 10.72 Billion in 2024 and is projected to reach USD 14.74 Billion by 2031, growing at a CAGR of 4.48% from 2024 to 2031.

The increasing population suffering from diabetes, causing diabetic macular edema in the patients, will help drive the growth of the Diabetic Macular Edema Market. The Global Diabetic Macular Edema Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Diabetic Macular Edema Market Definition

Diabetic macular edema is a type 1 or type 2 diabetes disease, and it’s a complication disease that occurs when extra fluid begins to build up in the eye’s macula, which causes vision problems. The macula helps in focusing and seeing fine details. It is found in the center of the retina, the lining at the rear of the eye full of blood vessels. Diabetic macular edema is developed due to high blood sugar levels that damage the retina’s blood vessels. Damaged blood vessels can squeal fluid, which causes swelling and other issues. This damage is named retinopathy. There are many treatment options for diabetic macular edema. The easiest way of treating is when it is analyzed earlier and regularly monitored by an eye care doctor.

Increasing blood sugar levels damage the small blood vessels in the eyes. High cholesterol levels also damage the blood vessels, which causes an increased risk for diabetic macular edema. Operating with your healthcare team to keep your blood sugar levels as near to target as possible is a vital part of keeping your eyes healthy. In cases of diabetes, pregnancy increases the risk of producing diabetic macular edema. The doctor may advise for frequent eye checkups during pregnancy.

Global Diabetic Macular Edema Market Overview

Increasing demand for the Global Diabetic Macular Edema Market is due to the increasing majority of eye disorders such as different forms of macular edema. The rising incidence of diabetes is increasing the incidence of diabetic macular edema. Moreover, increasing research and developments in treatment alternatives, increasing focus on preventative medical care via regular eye examinations, and increasing awareness regarding eye health are factors for the growth of the Global Diabetic Macular Edema Market. According to Centres for Disease Control and Prevention, in 2018, an estimated 34.2 million Americans had diabetes people suffering from diabetes. Many people develop type 1 and type 2 diabetes at a young age, and ethnic minorities resume developing type 2 diabetes at increased rates.

Controlling diabetes is made a health priority in developed countries like the U.S. The lack of attention is given to diabetic macular edema management and more focus on other diabetes complications. The anti-VEGF and corticosteroid therapies have changed diabetic macular edema. Still, there is a gap in clinical information among clinicians that hamper the market growth of the market. Whereas, improvement in ophthalmic surgery techniques and investment in research and development by various pharmaceutical companies are opportunities for the growth of the market.

Global Diabetic Macular Edema MarketSegmentation Analysis

The Global Diabetic Macular Edema Market is Segmented on the basis of Product, Distribution Channel, and Geography.

Diabetic Macular Edema Market, By Product

• Intravitreal Injections
• Intravitreal Implants

Based on Product, the market is segmented into Intravitreal Injections and Intravitreal Implants. The Intravitreal Injection segment holds a large number of shares in the market because it helps treat many retinal conditions, and diabetic retinopathy and retinal vein occlusion are the most common conditions treated with intravitreal anti-VEGF drugs due to its being easily available and cost-effective than Intravitreal Implants.

Diabetic Macular Edema Market, By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies

Based on Distribution Channel, the market is segmented into Retail Pharmacies and Hospital Pharmacies. The Hospital Pharmacies segment holds a large number of shares in the market because most of the countries globally use hospital pharmacies to deliver intravitreal injections and implants to outpatients, increasing the market growth of diabetic macular edema.

Diabetic Macular Edema Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Diabetic Macular Edema Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region holds a large number of shares in the market because of an increasing number of patients suffering from type-2 diabetes and the presence of top-tier photocoagulation lasers. The Asia-Pacific is the fastest-growing region in the market because of increasing incidence, awareness of ophthalmic disorders, and access to advanced technologies the factor for the growth of diabetic macular edema globally.

Key Players

The “Global Diabetic Macular Edema Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Pfizer Inc., Allergan PLC, Novartis AG, Clearside Biomedical Inc, Ariam Pharmaceuticals, Valeant Pharmaceuticals, Regenron PLC, Bayer AG, pSivida Corporation, Alimera Sciences Inc. The competitive landscape section also includes key development strategies, Market share, and Market ranking analysis of the above-mentioned players globally.

Key Developments

• On December 2018, Clearside Biomedical submitted a new medication, XIPERE, to treat macular edema associated with Uveitis.
• On May 2021, Faricimab (Roche), KSI 301 (Kodiak Sciences Inc.), and Beovu (Novartis) late-stage products have shown promising results in diabetic macular edema and are expected to improve the dosing interval.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.